Eli Lilly obesity pill disappoints in trial, sending shares down 12%
- Posted on August 7, 2025
- By Financial Times
- 4 Views
Eli Lilly obesity pill disappoints in trial, sending shares down 12%
Rival Novo Nordisk’s stock climbs 12%
